Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Els L. van Persijn van Meerten"'
Autor:
Fleur H.J. Kaptein, Tom van der Hulle, Sander J.E. Braken, Erik J. van Gennep, Jeroen T. Buijs, Mark C. Burgmans, Suzanne C. Cannegieter, Emma M.E. du Chatinier, Menno V. Huisman, Els L. van Persijn van Meerten, Henri H. Versteeg, Rob C.M. Pelger, Frederikus A. Klok
Publikováno v:
JACC. CardioOncology. 4(4)
Renal cell carcinoma (RCC) can be complicated by a venous tumor thrombus (TT), of which the optimal management is unknown.This study sought to assess the prevalence of TT in RCC, its current management, and its association with venous thromboembolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47191a4c98c800ef236177578af16583
https://pubmed.ncbi.nlm.nih.gov/36444235
https://pubmed.ncbi.nlm.nih.gov/36444235
Autor:
Thaïs M.L. Tong, Frank M. Speetjens, Monique K van der Kooij, C. Blank, Rutger W. van der Meer, Jacob Lutjeboer, Els L. van Persijn van Meerten, Arian R. van Erkel, Fred G.J. Tijl, Ellen Kapiteijn, Remco W. M. Zoethout, Chris H. Martini, Mark C. Burgmans
Background: While immune checkpoint inhibition (ICI) has revolutionized the treatment of metastatic cutaneous melanoma, no standard treatments are available for patients with metastatic uveal melanoma (UM). Several locoregional therapies are effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bf6e94d3b2d0648a130904fa30455a3
https://doi.org/10.21203/rs.3.rs-592047/v1
https://doi.org/10.21203/rs.3.rs-592047/v1
Autor:
Thaïs M.L. Tong, Mark C. Burgmans, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Carla S.P. van Rijswijk, Mare A. Jonker, Inge C.F.M. Roozen, Jacob Lutjeboer, Els L. van Persijn-van Meerten, Christian H. Martini, Remco W.M. Zoethout, Fred G.J. Tijl, Christian U. Blank, Ellen Kapiteijn
Publikováno v:
Journal of Clinical Oncology. 40:9560-9560
9560 Background: Uveal melanoma (UM) is the most frequent intraocular malignant tumor in adults. Approximately 50% of all patients (pts) will develop metastatic disease in the liver. Until now, there is no systemic therapy that has been shown to impr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5332382d909f54646ebc08a20e139f1c
https://doi.org/10.1200/jco.2022.40.16_suppl.9560
https://doi.org/10.1200/jco.2022.40.16_suppl.9560
Autor:
Lisanne S. Rigter, Marius Staring, E.C. Rijkmans, Doenja M. J. Lambregts, Baukelien van Triest, Ellen M. Kerkhof, Uulke A. van der Heide, Corrie A.M. Marijnen, Els L. van Persijn van Meerten, Roy P.J. van den Ende, Monique E. van Leerdam
Publikováno v:
Radiotherapy and Oncology, 132, 93-99
Background and purpose A GTV boost is suggested to result in higher complete response rates in rectal cancer patients, which is attractive for organ preservation. Fiducials may offer GTV position verification on (CB)CT, if the fiducial-GTV spatial re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf8d8cb74cf6c3d93f1ad14bc905e9e
https://hdl.handle.net/1887/119798
https://hdl.handle.net/1887/119798
Autor:
Thaïs M.L. Tong, Frank M. Speetjens, Remco W. M. Zoethout, Mare A. Jonker, Shelley van den Bosch, Monique K van der Kooij, Rutger W. van der Meer, Mark C. Burgmans, Els L. van Persijn van Meerten, Chris H. Martini, Fred G.J. Tijl, Inge Roozen, Jacob Lutjeboer, Christian U. Blank, Fenna Rijksen, Ellen Kapiteijn, Arian R. van Erkel
Publikováno v:
Journal of Clinical Oncology. 39:TPS9595-TPS9595
TPS9595 Background: Uveal Melanoma (UM), although rare, is the most common intraocular malignant tumor in adults. Despite successful treatment of the primary tumor, approximately half of all patients will develop metastatic disease, mainly in the liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa783c6a61a4df801c232311b75fd7cb
https://doi.org/10.1200/jco.2021.39.15_suppl.tps9595
https://doi.org/10.1200/jco.2021.39.15_suppl.tps9595
Publikováno v:
European Radiology
The purpose of this review article is to familiarize radiologists with the recently revised Response Evaluation Criteria in Solid Tumours (RECIST), used in many anticancer drug trials to assess response and progression rate. The most important modifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb623b13c9360ab23b8ce8f7f01f0d0
http://europepmc.org/articles/PMC2872013
http://europepmc.org/articles/PMC2872013
Autor:
Jo Hermans, Jeroen L. Turkenburg, Milan E. J. Pijl, Els L. van Persijn van Meerten, Johan L. Bloem
Publikováno v:
Journal of Magnetic Resonance Imaging. 9:369-372
The spleen-liver model, as a predictor for contrast-to-noise ratio (C/N) in liver metastases, was verified for seven sequences in 22 patients with 70 colorectal metastases. Optimization of conventional spin-echo, T1-magnetization-prepared gradient-ec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4589c737ed71b70bdf42b82085bf93d
https://doi.org/10.1002/(sici)1522-2586(199903)9:3<369::aid-jmri1>3.0.co
https://doi.org/10.1002/(sici)1522-2586(199903)9:3<369::aid-jmri1>3.0.co
Autor:
Edith M.G. van Esch, Margriet J. G. Löwik, Gijs Kerpershoek, Linda F. M. Stynenbosch, Mariette I.E. van Poelgeest, A. Rob P. M. Valentijn, Cornelis J. M. Melief, Dorien M A Berends-van der Meer, Gert Jan Fleuren, Muriel van den Hende, Els L. van Persijn van Meerten, Gemma G. Kenter, Lorraine M. Fathers, Sjoerd H. van der Burg, Jaap Oostendorp, Marij J. P. Welters
Publikováno v:
Journal of Translational Medicine, 11
Journal of Translational Medicine, 11:88. BioMed Central
van Poelgeest, M I, Welters, M J, van Esch, E M, Stynenbosch, L F, Kerpershoek, G, van Persijn-van Meerten, E L, van den Hende, M, Lowik, M J, Berends-van Meer, D M, Fathers, L M, Valentijn, A R, Oostendorp, J, Fleuren, G J, Melief, C J, Kenter, G G & van der Burg, S H 2013, ' HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial ', Journal of Translational Medicine, vol. 11, 88 . https://doi.org/10.1186/1479-5876-11-88
Journal of Translational Medicine
Journal of Translational Medicine, 11:88. BioMed Central
van Poelgeest, M I, Welters, M J, van Esch, E M, Stynenbosch, L F, Kerpershoek, G, van Persijn-van Meerten, E L, van den Hende, M, Lowik, M J, Berends-van Meer, D M, Fathers, L M, Valentijn, A R, Oostendorp, J, Fleuren, G J, Melief, C J, Kenter, G G & van der Burg, S H 2013, ' HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial ', Journal of Translational Medicine, vol. 11, 88 . https://doi.org/10.1186/1479-5876-11-88
Journal of Translational Medicine
Background Human papilloma virus type 16 (HPV16)-induced gynecological cancers, in particular cervical cancers, are found in many women worldwide. The HPV16 encoded oncoproteins E6 and E7 are tumor-specific targets for the adaptive immune system perm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcb64f54fcc4c626810f3a7491f42bd
http://hdl.handle.net/1887/97078
http://hdl.handle.net/1887/97078
Autor:
Liselot B. J. van Iersel, Hans Gelderblom, Ellen J. Hoekman, Johan W. R. Nortier, Henk H. Hartgrink, Cornelis J.H. van de Velde, Alexander L. Vahrmeijer, Peter J. K. Kuppen, Els L. van Persijn van Meerten, Rob A. E. M. Tollenaar, Fred G.J. Tijl
Publikováno v:
Annals of Surgical Oncology
Purpose The liver is one of the most common sites for metastatic solid tumors. If the liver is the only site of metastatic disease, regional treatment options can offer the benefit of high local exposure with limited systemic toxicity, especially for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be148c3fc700265e0b8a418b5d5355ae
https://doi.org/10.1245/s10434-008-9881-6
https://doi.org/10.1245/s10434-008-9881-6